166 related articles for article (PubMed ID: 37362864)
1. Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer.
Huang Z; Gao Y; Han Y; Yang J; Yang C; Li S; Zhou D; Huang Q; Yang J
Biosaf Health; 2023 May; ():. PubMed ID: 37362864
[TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of the
Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
[TBL] [Abstract][Full Text] [Related]
4. Systematic pan-cancer analysis identifies
Chen P; Yang X; Wang P; He H; Chen Y; Yu L; Fang H; Wang F; Huang Z
Ann Transl Med; 2023 Jan; 11(2):121. PubMed ID: 36819495
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the novel omicron receptor AXL in cancers.
Zhang WN; Li XP; Wang PF; Zhu L; Xiao XH; Dai YJ
Comput Struct Biotechnol J; 2022; 20():3304-3312. PubMed ID: 35782741
[TBL] [Abstract][Full Text] [Related]
10. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
Li L; Feng Q; Wang X
Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by
El-Hefnawy SM; Eid HA; Mostafa RG; Soliman SS; Omar TA; Azmy RM
Gene Rep; 2022 Jun; 27():101612. PubMed ID: 35463461
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
Song J; Han J; Liu F; Chen X; Qian S; Wang Y; Jia Z; Duan X; Zhang X; Zhu J
Front Mol Biosci; 2020; 7():569414. PubMed ID: 33195415
[TBL] [Abstract][Full Text] [Related]
15. RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Wu J; Yu X; Zhu H; Chen P; Liu T; Yin R; Qiang Y; Xu L
Front Mol Biosci; 2023; 10():1178446. PubMed ID: 37388242
[No Abstract] [Full Text] [Related]
16. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive pan-cancer analysis on the immunological role and prognostic value of
Yang Y; Jiang L; Wang S; Chen H; Yi M; Wu Y; Li Z; Fang X
Transl Cancer Res; 2022 Sep; 11(9):3187-3208. PubMed ID: 36237259
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of
Zhang S; Xiong H; Yang J; Yuan X
Front Mol Biosci; 2021; 8():792154. PubMed ID: 35155565
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
Zhao C; Liu Y; Ju S; Wang X
Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
